Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 16 | 2025 | 90 | 5.600 |
Why?
|
| Decision Making | 23 | 2023 | 249 | 5.130 |
Why?
|
| Marijuana Abuse | 15 | 2021 | 100 | 4.300 |
Why?
|
| Neuropsychological Tests | 39 | 2025 | 284 | 3.910 |
Why?
|
| Conduct Disorder | 6 | 2021 | 54 | 3.520 |
Why?
|
| Marijuana Smoking | 9 | 2018 | 91 | 2.840 |
Why?
|
| Adolescent Behavior | 7 | 2025 | 281 | 2.690 |
Why?
|
| Brain | 25 | 2025 | 1472 | 2.570 |
Why?
|
| Substance-Related Disorders | 27 | 2021 | 830 | 2.490 |
Why?
|
| Risk-Taking | 10 | 2019 | 457 | 2.320 |
Why?
|
| Cognition | 19 | 2025 | 473 | 2.100 |
Why?
|
| Adolescent | 43 | 2026 | 6081 | 2.010 |
Why?
|
| Gambling | 8 | 2023 | 21 | 1.900 |
Why?
|
| Schools | 3 | 2025 | 283 | 1.570 |
Why?
|
| Longitudinal Studies | 17 | 2026 | 1063 | 1.540 |
Why?
|
| Humans | 111 | 2026 | 43102 | 1.510 |
Why?
|
| Sex Characteristics | 8 | 2021 | 258 | 1.500 |
Why?
|
| Cognition Disorders | 13 | 2013 | 243 | 1.490 |
Why?
|
| Sexual Behavior | 5 | 2018 | 638 | 1.470 |
Why?
|
| HIV Infections | 21 | 2025 | 2586 | 1.420 |
Why?
|
| Male | 74 | 2026 | 23409 | 1.310 |
Why?
|
| Executive Function | 4 | 2025 | 59 | 1.280 |
Why?
|
| Female | 69 | 2026 | 24698 | 1.230 |
Why?
|
| Psychomotor Performance | 8 | 2015 | 159 | 1.200 |
Why?
|
| Reward | 4 | 2020 | 112 | 1.190 |
Why?
|
| Punishment | 2 | 2025 | 9 | 1.130 |
Why?
|
| Motivation | 4 | 2021 | 513 | 1.040 |
Why?
|
| Adolescent Development | 6 | 2025 | 40 | 1.020 |
Why?
|
| Child | 20 | 2026 | 3443 | 1.000 |
Why?
|
| Environmental Monitoring | 3 | 2025 | 230 | 0.970 |
Why?
|
| Feces | 3 | 2025 | 132 | 0.930 |
Why?
|
| Anxiety Disorders | 2 | 2018 | 322 | 0.900 |
Why?
|
| Learning | 7 | 2018 | 161 | 0.870 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 55 | 0.810 |
Why?
|
| Impulsive Behavior | 6 | 2015 | 55 | 0.810 |
Why?
|
| Attention | 6 | 2019 | 174 | 0.790 |
Why?
|
| Emotions | 3 | 2021 | 254 | 0.770 |
Why?
|
| Memory Disorders | 6 | 2023 | 77 | 0.760 |
Why?
|
| HIV Seropositivity | 11 | 2016 | 196 | 0.750 |
Why?
|
| Adult | 48 | 2025 | 13872 | 0.730 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2025 | 298 | 0.720 |
Why?
|
| Residence Characteristics | 1 | 2025 | 363 | 0.710 |
Why?
|
| Mental Recall | 5 | 2016 | 84 | 0.700 |
Why?
|
| Social Environment | 2 | 2021 | 218 | 0.660 |
Why?
|
| Coronavirus | 1 | 2020 | 9 | 0.660 |
Why?
|
| Psychometrics | 7 | 2021 | 358 | 0.650 |
Why?
|
| Depressive Disorder | 2 | 2018 | 187 | 0.640 |
Why?
|
| Cross-Sectional Studies | 10 | 2026 | 3156 | 0.630 |
Why?
|
| Amphetamine-Related Disorders | 4 | 2013 | 69 | 0.610 |
Why?
|
| Personality Assessment | 1 | 2019 | 45 | 0.600 |
Why?
|
| Cannabinoids | 3 | 2019 | 73 | 0.590 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.580 |
Why?
|
| Multilingualism | 1 | 2019 | 52 | 0.570 |
Why?
|
| Mood Disorders | 1 | 2018 | 54 | 0.540 |
Why?
|
| Mental Disorders | 4 | 2026 | 392 | 0.530 |
Why?
|
| Young Adult | 15 | 2019 | 5080 | 0.530 |
Why?
|
| Body Mass Index | 3 | 2023 | 925 | 0.530 |
Why?
|
| Methamphetamine | 4 | 2007 | 166 | 0.510 |
Why?
|
| Prospective Studies | 8 | 2026 | 1600 | 0.510 |
Why?
|
| Drug Monitoring | 1 | 2017 | 69 | 0.500 |
Why?
|
| Auditory Perception | 2 | 2006 | 70 | 0.470 |
Why?
|
| Anti-HIV Agents | 3 | 2017 | 486 | 0.460 |
Why?
|
| Drug Resistance, Microbial | 2 | 2025 | 27 | 0.460 |
Why?
|
| Mental Processes | 2 | 2012 | 16 | 0.450 |
Why?
|
| Middle Aged | 31 | 2025 | 12222 | 0.440 |
Why?
|
| Alcoholism | 4 | 2025 | 305 | 0.430 |
Why?
|
| Anxiety | 3 | 2017 | 874 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2025 | 587 | 0.400 |
Why?
|
| United States | 9 | 2026 | 5205 | 0.400 |
Why?
|
| Sewage | 2 | 2025 | 27 | 0.390 |
Why?
|
| Choice Behavior | 2 | 2013 | 93 | 0.380 |
Why?
|
| Mental Health | 3 | 2026 | 385 | 0.370 |
Why?
|
| Heroin Dependence | 4 | 2015 | 23 | 0.370 |
Why?
|
| Amygdala | 3 | 2021 | 125 | 0.360 |
Why?
|
| Serial Learning | 1 | 2011 | 5 | 0.350 |
Why?
|
| Memory | 3 | 2013 | 174 | 0.340 |
Why?
|
| Individuality | 2 | 2022 | 54 | 0.330 |
Why?
|
| Analysis of Variance | 7 | 2017 | 575 | 0.320 |
Why?
|
| Disasters | 2 | 2022 | 79 | 0.320 |
Why?
|
| Cyclonic Storms | 2 | 2021 | 80 | 0.310 |
Why?
|
| Reproducibility of Results | 6 | 2019 | 1081 | 0.270 |
Why?
|
| Demography | 3 | 2006 | 195 | 0.260 |
Why?
|
| Risk Factors | 6 | 2026 | 3994 | 0.250 |
Why?
|
| Gyrus Cinguli | 3 | 2021 | 31 | 0.250 |
Why?
|
| Case-Control Studies | 4 | 2017 | 1285 | 0.250 |
Why?
|
| Sex Factors | 3 | 2019 | 1028 | 0.240 |
Why?
|
| AIDS Dementia Complex | 2 | 2004 | 116 | 0.220 |
Why?
|
| Virginia | 2 | 2025 | 12 | 0.220 |
Why?
|
| Follow-Up Studies | 3 | 2023 | 1067 | 0.220 |
Why?
|
| Rain | 1 | 2024 | 10 | 0.220 |
Why?
|
| Exploratory Behavior | 1 | 2005 | 78 | 0.220 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2004 | 38 | 0.210 |
Why?
|
| Drug Users | 3 | 2015 | 52 | 0.210 |
Why?
|
| Virus Inactivation | 1 | 2024 | 2 | 0.210 |
Why?
|
| Disinfection | 1 | 2024 | 10 | 0.210 |
Why?
|
| Sleep | 1 | 2026 | 185 | 0.210 |
Why?
|
| Water Microbiology | 1 | 2024 | 81 | 0.210 |
Why?
|
| Ozone | 1 | 2024 | 26 | 0.210 |
Why?
|
| Social Behavior | 1 | 2025 | 161 | 0.210 |
Why?
|
| Depression | 3 | 2023 | 863 | 0.210 |
Why?
|
| Water Purification | 1 | 2024 | 32 | 0.210 |
Why?
|
| Comorbidity | 4 | 2018 | 737 | 0.210 |
Why?
|
| Hepatitis C | 3 | 2015 | 139 | 0.200 |
Why?
|
| Cubozoa | 1 | 2023 | 16 | 0.200 |
Why?
|
| Computers | 1 | 2003 | 35 | 0.190 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 164 | 0.180 |
Why?
|
| Mass Media | 1 | 2021 | 39 | 0.180 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2021 | 568 | 0.180 |
Why?
|
| Pancreas, Exocrine | 1 | 2021 | 4 | 0.170 |
Why?
|
| Empathy | 1 | 2021 | 33 | 0.170 |
Why?
|
| Rotavirus | 1 | 2021 | 14 | 0.170 |
Why?
|
| Enterovirus | 1 | 2021 | 11 | 0.170 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2023 | 192 | 0.170 |
Why?
|
| Disease Management | 1 | 2021 | 70 | 0.170 |
Why?
|
| Intelligence | 2 | 2019 | 15 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 497 | 0.160 |
Why?
|
| Personality | 3 | 2021 | 55 | 0.160 |
Why?
|
| Drug Interactions | 2 | 2015 | 150 | 0.160 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 67 | 0.160 |
Why?
|
| Students | 1 | 2025 | 626 | 0.150 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 100 | 0.150 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 51 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 652 | 0.150 |
Why?
|
| Vocabulary | 1 | 2019 | 21 | 0.150 |
Why?
|
| Medication Adherence | 1 | 2021 | 182 | 0.150 |
Why?
|
| Antisocial Personality Disorder | 2 | 2010 | 20 | 0.150 |
Why?
|
| Reaction Time | 4 | 2010 | 157 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2019 | 137 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2021 | 1759 | 0.140 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 162 | 0.140 |
Why?
|
| Socioeconomic Factors | 3 | 2025 | 1234 | 0.140 |
Why?
|
| Behavior, Addictive | 1 | 2018 | 37 | 0.140 |
Why?
|
| Aggression | 1 | 2019 | 102 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 218 | 0.140 |
Why?
|
| Models, Statistical | 1 | 2019 | 195 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 174 | 0.140 |
Why?
|
| Verbal Learning | 3 | 2013 | 18 | 0.130 |
Why?
|
| Self Administration | 1 | 2017 | 69 | 0.130 |
Why?
|
| Social Class | 1 | 2019 | 291 | 0.130 |
Why?
|
| Regression Analysis | 3 | 2013 | 490 | 0.130 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2016 | 2 | 0.120 |
Why?
|
| Behavior | 1 | 2016 | 35 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 609 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2019 | 666 | 0.120 |
Why?
|
| Parents | 1 | 2019 | 370 | 0.110 |
Why?
|
| Cocaine-Related Disorders | 3 | 2016 | 102 | 0.110 |
Why?
|
| Age of Onset | 1 | 2015 | 114 | 0.110 |
Why?
|
| Intelligence Tests | 2 | 2011 | 8 | 0.110 |
Why?
|
| Reference Values | 2 | 2012 | 211 | 0.100 |
Why?
|
| Buttocks | 1 | 2013 | 3 | 0.100 |
Why?
|
| Silicone Gels | 1 | 2013 | 2 | 0.100 |
Why?
|
| Statistics as Topic | 2 | 2013 | 123 | 0.100 |
Why?
|
| Visual Perception | 2 | 2016 | 80 | 0.100 |
Why?
|
| Time Factors | 3 | 2023 | 1857 | 0.100 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 18 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2013 | 226 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2013 | 140 | 0.100 |
Why?
|
| Cannabidiol | 1 | 2012 | 10 | 0.100 |
Why?
|
| Educational Status | 2 | 2019 | 339 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 317 | 0.090 |
Why?
|
| Memory, Short-Term | 2 | 2013 | 59 | 0.090 |
Why?
|
| Personality Inventory | 2 | 2016 | 82 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2013 | 408 | 0.080 |
Why?
|
| Unsafe Sex | 2 | 2010 | 162 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2012 | 440 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 18 | 0.080 |
Why?
|
| Suicide, Attempted | 1 | 2012 | 108 | 0.080 |
Why?
|
| Motor Skills | 1 | 2010 | 46 | 0.080 |
Why?
|
| Games, Experimental | 1 | 2009 | 4 | 0.080 |
Why?
|
| Hippocampus | 3 | 2021 | 594 | 0.080 |
Why?
|
| Affective Symptoms | 1 | 2010 | 63 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 2 | 2025 | 125 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 279 | 0.080 |
Why?
|
| Severity of Illness Index | 5 | 2016 | 719 | 0.070 |
Why?
|
| Age Factors | 3 | 2006 | 1154 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2012 | 2544 | 0.070 |
Why?
|
| Smoking | 1 | 2015 | 1024 | 0.070 |
Why?
|
| Homosexuality, Male | 1 | 2013 | 486 | 0.070 |
Why?
|
| Stroop Test | 2 | 2021 | 2 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 53 | 0.060 |
Why?
|
| Aspartic Acid | 2 | 2005 | 51 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2007 | 162 | 0.060 |
Why?
|
| Animals | 3 | 2023 | 16992 | 0.060 |
Why?
|
| Reference Standards | 1 | 2006 | 55 | 0.060 |
Why?
|
| Didanosine | 1 | 2005 | 3 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 282 | 0.060 |
Why?
|
| Mitochondrial Diseases | 1 | 2005 | 20 | 0.060 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2005 | 57 | 0.060 |
Why?
|
| Waste Disposal, Fluid | 1 | 2025 | 19 | 0.060 |
Why?
|
| Temperament | 1 | 2005 | 36 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 111 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 611 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 141 | 0.050 |
Why?
|
| Verbal Behavior | 1 | 2004 | 12 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 180 | 0.050 |
Why?
|
| Eclampsia | 1 | 2023 | 12 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 386 | 0.050 |
Why?
|
| Language | 1 | 2005 | 185 | 0.050 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2015 | 44 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2003 | 22 | 0.050 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 27 | 0.050 |
Why?
|
| Birth Weight | 1 | 2023 | 95 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 67 | 0.050 |
Why?
|
| Psychopathology | 1 | 2021 | 20 | 0.040 |
Why?
|
| Personality Disorders | 1 | 2021 | 21 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 46 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2021 | 12 | 0.040 |
Why?
|
| Task Performance and Analysis | 1 | 2021 | 47 | 0.040 |
Why?
|
| Filtration | 1 | 2021 | 17 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 45 | 0.040 |
Why?
|
| Oncogenes | 1 | 2021 | 44 | 0.040 |
Why?
|
| Awareness | 1 | 2021 | 73 | 0.040 |
Why?
|
| Kenya | 1 | 2021 | 58 | 0.040 |
Why?
|
| Organoids | 1 | 2021 | 37 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 321 | 0.040 |
Why?
|
| Rural Population | 1 | 2023 | 373 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 119 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2021 | 142 | 0.040 |
Why?
|
| Stem Cells | 1 | 2021 | 152 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 478 | 0.040 |
Why?
|
| Prevalence | 2 | 2019 | 1612 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 384 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 66 | 0.040 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2018 | 4 | 0.040 |
Why?
|
| Habits | 1 | 2018 | 8 | 0.040 |
Why?
|
| South America | 1 | 2018 | 24 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2018 | 34 | 0.040 |
Why?
|
| North America | 1 | 2018 | 85 | 0.040 |
Why?
|
| Europe | 1 | 2018 | 115 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 98 | 0.040 |
Why?
|
| Australia | 1 | 2018 | 103 | 0.040 |
Why?
|
| Compulsive Behavior | 1 | 2018 | 31 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 263 | 0.030 |
Why?
|
| Aged | 2 | 2012 | 8214 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 972 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 1772 | 0.030 |
Why?
|
| Personality Tests | 1 | 2016 | 7 | 0.030 |
Why?
|
| Culture | 1 | 2018 | 172 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 1546 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 252 | 0.030 |
Why?
|
| Legislation, Drug | 1 | 2016 | 5 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 458 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 113 | 0.030 |
Why?
|
| ROC Curve | 2 | 2004 | 159 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2013 | 7 | 0.030 |
Why?
|
| Reading | 1 | 2013 | 13 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 87 | 0.030 |
Why?
|
| Chicago | 1 | 2013 | 31 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2005 | 301 | 0.020 |
Why?
|
| Hypertension | 1 | 2019 | 835 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2012 | 15 | 0.020 |
Why?
|
| Association Learning | 1 | 2012 | 35 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2013 | 233 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2013 | 195 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 263 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 509 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 70 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 116 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 56 | 0.020 |
Why?
|
| HIV Seronegativity | 1 | 2007 | 41 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 236 | 0.020 |
Why?
|
| Putamen | 1 | 2006 | 16 | 0.020 |
Why?
|
| Stavudine | 1 | 2005 | 13 | 0.010 |
Why?
|
| Lamivudine | 1 | 2005 | 22 | 0.010 |
Why?
|
| Zidovudine | 1 | 2005 | 32 | 0.010 |
Why?
|
| Cell Respiration | 1 | 2005 | 35 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 224 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2004 | 95 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 10 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 306 | 0.010 |
Why?
|
| Semantics | 1 | 2004 | 29 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2003 | 12 | 0.010 |
Why?
|
| Creatine | 1 | 2003 | 10 | 0.010 |
Why?
|
| Inositol | 1 | 2003 | 20 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 667 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2003 | 58 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 883 | 0.010 |
Why?
|
| Mitochondria | 1 | 2005 | 523 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 437 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 259 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 1604 | 0.010 |
Why?
|
| Aging | 1 | 2005 | 783 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 549 | 0.010 |
Why?
|